Thursday, 8 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Auro Laboratories Ltd

NSE: AUROLAB · BSE: 530233 · Pharmaceuticals & Biotechnology · 15 announcements

Auro Laboratories Ltd news stories on ALFA NewsRead the news →
Share price
₹232.55
Market cap
₹144.9 Cr
Revenue (annual)
₹32.61 Cr
Net profit (annual)
₹3.53 Cr
P/E (TTM)
30.9×Sector 47.3×
Promoter holding
52.40%+0.22% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

19:27 IST BSE
Annual General Meeting

Auro Laboratories Annual General Meeting

Auro Laboratories Limited held its 37th Annual General Meeting on August 11, 2026, via video conferencing. The company conducted all items of business as listed in the notice.

19:03 IST BSE
Board Meeting Date

Auro Laboratories Board Meeting Date

Auro Laboratories Ltd has scheduled a board meeting on August 14, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.

18:45 IST BSE
Other Announcement

Auro Laboratories Other Announcement

Auro Laboratories issued a notice to shareholders regarding its 37th AGM scheduled for August 11, 2026. The letter provides web-links to access the FY 2025-26 Annual Report.

18:24 IST BSE
Annual General Meeting

Auro Laboratories Annual General Meeting

Auro Laboratories has scheduled its 37th Annual General Meeting for August 11, 2026. Agenda includes adopting financial statements and re-appointing Mr. Kiran Kulkarni as Whole-Time Director.

18:22 IST BSE
Annual Report

Auro Laboratories Annual Report

Auro Laboratories released its Annual Report for FY 2025-26. The 37th Annual General Meeting is scheduled for August 11, 2026, via video conferencing.